A direct association between exposure to the metalloid selenium and risk of cutaneous melanoma has been suggested by some observational and experimental cohort studies, whereas other studies have yielded inconsistent results. Since some of the inconsistencies may be due to exposure misclassification arising from the use of exposure indicators that do not adequately reflect body tissue selenium content or the levels of the biologically relevant species of this metalloid, we examined this issue using multiple indicators of exposure.
Introduction
The relation of metalloid selenium to human health and particularly cancer is puzzling. While some observational studies have suggested a chemo-preventative effect of selenium, a recent large trial and a meta-analysis by the Cochrane Collaboration found that there is currently no convincing evidence that selenium supplements can prevent cancer in humans 1, 2 . Other studies have suggested the possibility of increased cancer risk 1, 2 . The possibility that exposure to selenium may increase the risk of melanoma was suggested in the 1990's by the observation of an excess risk of the cancer in a residential cohort consuming unusually high levels of the element in its inor-ganic hexavalent form, selenate, through drinking water 3 . Other prospective observational investigations examining the relation between indicators of selenium exposure and melanoma risk have yielded inconsistent results [4] [5] [6] [7] . Studies of the relation between selenium and other cancers and chronic diseases have also variously found beneficial, null and adverse effects 1, [8] [9] [10] [11] . More recently, an excess melanoma incidence in females, but not in males, was reported from an intervention trial with vitamins C and E, β-carotene, zinc and organic selenium in French adults 12 ; no further increased incidence was observed after stopping supplementation 13 . A slight and imprecise increase in melanoma risk was observed in a US trial that supplemented organic selenium with selenized yeast 14 . No data on melanoma risk were reported in another large trial that administered selenium in the organic form of L-selenomethionine 1 .
Some of the inconsistencies in the literature regarding the relation of selenium with melanoma risk may be due to exposure misclassification. In particular, null findings could be due to the use of exposure indicators that do not adequately reflect body tissue selenium content or the biologically active species of the metalloid. In the present study, we aimed to analyze the relation among three indicators of selenium exposure -plasma selenium concentration, toenail selenium concentration and dietary intake -and the relation of these indicators with the risk of cutaneous melanoma in a casecontrol series from an Italian community.
Methods

Study participants
We carried out the present study on a series of melanoma patients and controls originally enrolled in a community-based study of environmental and life-style risk factors of cutaneous melanoma, as reported in detail elsewhere [15] [16] [17] [18] . Fifty-nine individuals residing in the province of Modena, northern Italy (population around 700,000), were recruited at the Department of Dermatology of Modena and Reggio Emilia University following the diagnosis of cutaneous melanoma from 1999 to 2002. Immediately after enrollment of each patient, which occurred at the beginning of clinical follow-up, we recruited one population control matched to the case for sex, age (± 5 years) and residence in the province, by approaching by telephone potential participants identified from a general population database made available by the Local Health Unit of Reggio Emilia. All controls were recruited within three months of enrollment of the corresponding case, in most cases within one month. The participation rate was 72.0% for cases, drawn from a consecutive series of patients, and 56.3% for referents.
After obtaining written informed consent from each participant, we carried out a dermatological examination and administered questionnaires to assess demographic characteristics, family history of melanoma, life-style factors including history of sunburns and other indicators of sun exposure, and a dietary assessment. Study participants also provided blood and toenail specimens.
Dietary intake of selenium
For the dietary assessment, we used a semiquantitative food frequency questionnaire specifically developed for northern Italy that included 248 questions on frequency and quantity of consumption of 188 items. The questionnaire, developed and validated by the EPIC (European Prospective Investigation on Cancer and Nutrition) project 19, 20 , carried 17 sets of illustrations of sample dishes of small, medium and large proportions and took into consideration cooking procedures and alcohol and beverage consumption. The questionnaires were read by expert personnel using an optical reader at the Milan National Cancer Institute Nutritional Epidemiology Unit, and the overall selenium dietary intake was obtained by linking the food consumption data to a nutritional database for selenium that was specifically developed by the authors of the present study using published data and ad hoc food analyses, using a methodology previously described in detail 10 . Dietary data were missing for 3 cases.
Toenail selenium concentration
Right foot toenail clippings were obtained from the participants, cleaned, dried and analyzed using instrumental neutron activation analysis at the Helmholtz Center (former 'Hahn-Meitner Institute') in Berlin, Germany, as reported in detail elsewhere 16 .
Plasma selenium concentration
Fasting venous blood samples were collected in ED-TA-containing plastic tubes, immediately centrifuged for 10 min at 3000 rpm and stored at -20 °C until use in aliquots of 1 ml. Blood samples from five cases and three controls were unavailable for analysis, and therefore the present study is limited to 110 of the 118 original study participants. Selenium plasma concentrations were determined using a direct electrothermal atomic absorption spectrometer (AAnalyst 600, Perkin-Elmer). Pd and Mg(NO 3 ) 2 matrix modifiers and a transverseheated graphite atomizer with an integrated pyrolytic graphite-coated platform and longitudinal Zeeman-effect background correction were used. A standard calibration curve, ranging from 10 to 40 µg/l of Se, was prepared, adding to a pool of plasma different volumes of the stock standard solution of sodium selenite (Sigma Aldrich). The calibration blank was a pool of plasma itself. To evaluate the performance of the procedure, a certified reference material, BCR 638 (IRMM Institute of Reference Materials and Measurement), containing 104 ± 7 µg/l of selenium, was used. All plasma samples were prepared daily by dilution at 1:5 v/v in double-distilled water. Volumes of 20 l of all samples were injected into the graphite furnace with 5 l of matrix modifier solution. The temperature program, optimized for selenium determination in serum/plasma samples, provides pyrolysis and atomization temperatures at 1200 °C and 1900 °C, respectively. An electrode discharge lamp was used for selenium and the 'end-capped' graphite tubes for volatile elements such as selenium.
Data analysis
The distributions of each of the three selenium measures for cases and controls were compared using twosample Student's t test. The associations among the three measures were quantified using Spearman rank correlation coefficients; this rank-based measure of association was used rather than Pearson correlation coefficients to reduce the influence of several moderate outliers. The relative risk (RR) of cutaneous melanoma associated with each indicator of selenium exposure was estimated by computing odds ratios in conditional and unconditional logistic regression models. Conditional logistic regression models used the case-control matching; unconditional logistic regression models controlled for age and gender. Each selenium exposure indicator was examined both as a categorical and a continuous predictor. We also fit multivariate models controlling for education (dichotomized as high school graduate or higher versus less than high school), phototype (dichotomized as Type I or II versus III or IV) and history of sunburns (dichotomized as any versus none). These analyses were conducted using Stata 11.1 (Stata-Corp, College Station, TX 2010).
Nonparametric estimates of the relation between melanoma risk and selenium exposure indicators were obtained while controlling for potential confounders using a generalized additive model 21 . The estimates were obtained using a natural cubic smoothing spline, with interior and boundary knots at the unique values of selenium level. The analyses were conducted using the gam package in R version 2.9.2 22 .
Results
Demographic and clinical characteristics of the cases and controls are given in Table 1 . The subjects ranged in age from 25 to 79 years, and men and women were about equally represented. About half of the subjects had less than a high school education. As expected, cases tended to have lighter photoypes than controls, and also were more likely to report a history of sunburns or a family history of melanoma.
The distributions of plasma and toenail selenium concentration and dietary selenium intake in cases and controls are reported in Table 2 . Plasma selenium levels showed a clear tendency towards higher levels in patients than in referents, with differences more pronounced for females than for males and for the youngest subjects (data not shown). The distributions of toenail selenium concentration and dietary selenium intake were similar between cases and controls, when considering the sample overall and stratified by age and sex. In the study sample as a whole, dietary selenium was mainly due to intake of fish (28% of overall intake), meat (22.7%), cereals (14.9%) and dairy products (12.6%), whereas the remaining food groups were minor contributors.
In the overall sample, plasma selenium was weakly correlated with toenail concentration (Spearman rank correlation coefficient r s = 0.22, P = 0.022) and other correlations were near zero ( Table 3 ). In analysis by disease status, the estimated correlations between plasma and toenail selenium were similar in magnitude among cases and controls, and there was positive correlation between plasma levels and dietary intake among cases but not controls (Table 3) .
In unmatched and matched logistic regression models using quartiles of plasma selenium in the overall sample as explanatory variables, higher selenium levels were strongly associated with excess disease risk ( Table  4 ). The relative risk estimates remained similar when adjusting for potential confounders including education, phototype and sunburn history, and when restricting the analysis to subjects without a family history of melanoma (results not shown). Family history of melanoma could not be used as a predictor due to incomplete data and small numbers. Using plasma selenium concentration as a continuous variable, a 10 µg/l increase was associated with a RR of 1.41 (95% CI, 1.11-1.79, P = 0.005) in a matched analysis and 1.43 (95% CI, 1.15-1.78, P = 0.001) in unmatched analysis, with control for age and sex only. Table 5 provides results of a multivariate analysis using plasma selenium as a continuous variable and controlling for age, sex, education, phototype and sunburn history. The RR estimate was similar after these adjustments (1.43, 95% CI, 1.13-1.81, P = 0.003). Further restricting the analysis to the subset of subjects without a family history of melanoma also yielded a similar estimate (1.38, 95% CI, 1.07-1.77, P = 0.012). Toenail and dietary selenium exhibited far less consistent evidence of a relation with melanoma risk. In analyses using quartiles of exposure indicators (Table  4 ), point estimates of RR were below unity for the highest exposure categories but above or near unity for middle exposure categories. The RR of the disease associated with a 0.1 µg/g increase in toenail selenium concentration in an unconditional logistic model adjusting for sex and age was 0.87 (95% CI 0.60-1.27, P = 0.470), whereas the corresponding estimate for a 10 µg/day increase in dietary selenium was 0.99 (95% CI, 0.83-1.19, P = 0.943). Adjusting for education, phototype and history of sunburns in multivariate analysis did not appreciably change these estimates ( Table 5 ). Figure 1 shows the nonparametric estimates of the relation between melanoma risk and each of the three selenium exposure indicators from a generalized additive model, controlling for age, sex, education, phototype and history of sunburn. The estimates support the appropriateness of modeling the exposure indicators as linear on the log odds scale, as was done in the analyses of Table 5 . The nonparametric results suggest a strongly positive association with plasma selenium level. This estimated relation was similar after removal of two potentially influential observations, namely, the subjects with the lowest and highest plasma selenium values (figure not provided). Generalized additive models for toenail and dietary selenium suggested null associations.
Discussion and conclusion
In the study, we found that different selenium exposure indicators yielded different relations with risk of cutaneous melanoma. We observed a strong positive association between plasma selenium levels and risk of melanoma 12, 14, 23 . We did not observe an association between melanoma risk and toenail selenium, as previously reported in this population 16 .
Although toenail selenium is expected to better reflect long-term intake of the metalloid compared with circulating levels 24 , some evidence from laboratory studies 290 M VINCETI, CM CRESPI, C MALAGOLI ET AL indicates that the various chemical forms of selenium may be associated with different distributions in body tissues 25 notwithstanding comparable overall selenium intake, suggesting that differences in specific selenium compounds might explain the different behavior of plasma and toenail levels in predicting the melanoma risk we observed in the present study. Such results also suggest the importance of circulating levels of selenium in influencing disease risk compared with levels characterizing other body compartments, emphasizing the importance of a comprehensive approach when estimating selenium exposure and assessing its health effects 2 . We observed a low or null association of estimated dietary selenium intake with plasma selenium levels as well as with melanoma risk in the overall study sample, not an entirely unexpected finding due to that observed in some populations [26] [27] [28] [29] but not in others [30] [31] [32] . The lack of concordance is generally explained by inaccuracies in dietary histories, variability of selenium levels in foodstuffs and absorption rates of the ingested metalloid during the digestive process, and the influence of additional sources of selenium exposure apart from dietary intake, such as smoking, occupational settings and environmental pollution 24, 33, 34 . However, when we stratified the study sample according to disease status, dietary intake was associated with plasma selenium levels in patients but not in controls. This difference related to disease status could be due to chance. However, it might indicate some difference in the chemical forms of ingested selenium between the two groups or in their metabolic pathways within the body, factors which may in turn be related to excess disease risk. The possibility also exists that a direct relation between selenium exposure and melanoma risk is induced by different individual patterns in element detoxification due to genetic or non-genetic factors or by its specific chemical forms, which may exert different toxic effects even at equivalent amounts of overall selenium ingestion 35 .
The magnitude of our risk estimates for plasma selenium were roughly in line with those reported in two intervention trials, despite the low number of melanoma cases on which the analysis was based in those studies 12, 14 . Interestingly, in the former trial, a slight increase in melanoma incidence was accompanied by an increased risk of basal cell carcinoma and, in particular, of squamous cell carcinoma, an observation which the investigators judged to be causally related to the antecedent selenium supplementation 23 and which suggests that skin may be a target organ of selenium toxicity. In a clinical trial carried out in 184 organ transplant recipients, treatment with 200 µg/day of selenium for three years was associated with a 3.08 RR of skin cancer, although this estimate was statistically imprecise being based on six cases that occurred in exposed subjects and on two in unexposed subjects 36 .
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M VINCETI, CM CRESPI, C MALAGOLI ET AL The biological plausibility of the selenium-melanoma relation is an issue of major importance. Whereas for other diseases such as diabetes and amyotrophic lateral sclerosis laboratory studies have provided strong support for an association with selenium, particularly in recent years 11, 37 , an association between cutaneous melanoma and selenium is less well established. In laboratory studies, selenium compounds have been shown to induce immunotoxicity 38 , genotoxicity [39] [40] [41] and oxidative stress 41, 42 at doses as low as those found in our study, and to affect Akt enzymatic activity 43 and p53 expression 44, 45 , mechanisms which have been implicated in melanoma etiopathogenesis 46 , although neither of these effects clearly confirms a specific activity of selenium in inducing melanoma onset or progression. Inorganic tetravalent selenium has also been shown to act as an environmental estrogen 47 , and some epidemiologic data indicate that estrogens increase melanoma risk 48 , but evidence on this point is limited and controversial 49, 50 . Selenium has also been shown to be carcinogenic in some studies [51] [52] [53] [54] , but none of these investigations included animal or in vitro models of cutaneous melanoma.
To adequately compare our findings to those yielded by laboratory studies, we should know which kind of selenium species are present in the blood of the study subjects, information that is unfortunately unavailable in our sample as well as more generally in almost all epidemiologic studies, to our knowledge 2 . The laboratory methodologies generally used to determine selenium content of biological indicators or of diet are unable to identify the specific inorganic and organic compounds, although we know that nearly all selenium provided by diet, usually its major source, is in organic forms 55 . This represents a major limitation since laboratory studies show that biological effects of the different selenium species strongly differ [56] [57] [58] , even leading to entirely opposite effects 59 . Application of more advanced analytical methodologies and selenium speciation in epidemiologic studies may be of major importance to elucidate the intriguing relation between the metalloid selenium and human health.
The relation we observed between selenium and melanoma risk occurred at overall levels of selenium exposure that have been considered to be in the 'safe' range, i.e., in a population having median values of intake around 60 µg/day and plasma levels near 95 µg/l. However, recent epidemiologic 1, [9] [10] [11] 60 and laboratory studies 38, [40] [41] [42] 61 have suggested or demonstrated that selenium toxicity occurs at levels lower than previously believed 62 .
Several limitations must be acknowledged. The first caveat is the small size of the study, consisting of a total of 110 subjects. However, despite the small sample size, we observed a strong exposure-risk effect across the distribution of plasma selenium concentrations represented in the sample, and the size of the effect was stable after adjustment for several potential risk factors. A non-experimental study such as the present one also has a serious risk of confounding, even after adjusting for or stratifying on known potential risk factors such as family history of disease, phototype and history of sunburns. We conducted limited adjustments for sun-related variables because we were concerned about the potential for recall bias or inaccuracies for self-reported measures of sun exposure, such as sunburn history, time or days spent outdoors or at sea or travels to tropical countries. However, when we also included the two latter variables in the regression model, results changed little, and this was also true when taking into account vitamin D intake, being a potential protective factor for melanoma at least in the Italian population 63 (results not shown). Nevertheless, it is still possible that the relation we detected between selenium and melanoma is not due to a true effect of the metalloid, but rather to other risk factors not included in our analysis. We also note the null results of the only other population-based case-control study examining the relation between selenium and melanoma to date 64 , though the individuals examined in that investigation, drawn from Oahu, Hawaii, were characterized by much higher selenium levels than those experienced by our subjects and likely had a different pattern of melanoma risk factors.
In conclusion, our data demonstrate that findings regarding the relation between selenium and melanoma risk can be highly dependent on the nature of the exposure indicator. Our finding of a positive association with plasma selenium call for further epidemiological evidence on the issue, such as an analysis of melanoma incidence among selenium-administered subjects from a recent large trial 1 and in individuals heavily exposed to selenium compounds from environmental or occupational sources. Advancements in analytical methodologies and their application in epidemiologic studies and studies of metabolic patterns are also needed to better understand the relation between selenium and melanoma, as well as other diseases. In the meantime and until new evidence on this issue is available, these findings add to the increasing epidemiologic evidence 1,2,10,11,60,65 suggesting caution in increasing selenium exposure, particularly among subjects already at high risk of melanoma.
